课题基金 / 基金详情

Studies on the stereospecific interaction between aldose reductase and inhibitor

Studies on the stereospecific interaction between aldose reductase and inhibitor
醛糖还原酶与抑制剂立体特异性相互作用的研究
批准号:
LP0560652
负责人:
A/Prof Ossama El-Kabbani
金额:
$5.9万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Linkage Projects
财政年份:
2005
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2005-01-01 至 2006-12-31

项目摘要

项目成果

A/Prof Ossama El-Kabbani的其他基金

相似基金

相关文献

中文摘要
翻译
对于糖尿病并发症的治疗,全世界都没有特效药。醛糖还原酶作为预防或延缓并发症发生的药物靶点,已显示出良好的效果。人醛糖还原酶全酶与强效抑制剂Fidarestat的立体异构体的复合体的结构将被高分辨率测定,以阐明导致其抑制效力差异的结合模式。这一结果可能会导致设计出更好的酶抑制剂来治疗糖尿病患者,至少在找到更好的维持代谢控制的方法之前是这样。
英文摘要
There is no therapy specific for treatment of diabetes complications accepted worldwide. The enzyme aldose reductase has shown promising results as a drug target for preventing or delaying the onset of the complications. The structures of human aldose reductase holoenzyme in complex with stereoisomers of the potent inhibitor Fidarestat will be determined at high resolution in order to elucidate the binding modes responsible for the differences in their inhibitory potencies. The results may lead to the design of better inhibitors of the enzyme for the treatment of diabetes sufferers, at least until better methods for maintaining metabolic control are developed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structure-based discovery of dipeptidyl peptidase IV inhibitors
  • 批准号:
    LP0562573
  • 项目类别:
    Linkage Projects
  • 资助金额:
    $5.55万
  • 财政年份:
    2006
  • 负责人:
    A/Prof Ossama El-Kabbani
  • 依托单位:
Structural studies of mammalian dimeric dihydrodiol dehydrogenase and L-xylulose reductase
  • 批准号:
    LX0347903
  • 项目类别:
    Linkage - International
  • 资助金额:
    $3.77万
  • 财政年份:
    2003
  • 负责人:
    A/Prof Ossama El-Kabbani
  • 依托单位:
海外基金